Natixis Advisors, L.P. Ptc Therapeutics, Inc. Transaction History
Natixis Advisors, L.P.
- $54.1 Billion
- Q1 2025
A detailed history of Natixis Advisors, L.P. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 15,220 shares of PTCT stock, worth $766,479. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,220
Previous 12,060
26.2%
Holding current value
$766,479
Previous $544,000
42.65%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
295Shares Held
79.2MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$433 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$391 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$377 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$274 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$273 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.6B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...